|
Antibiotics in the News
12-23-10 New antibiotics — Stat
As resistance builds to today’s drugs, FDA must help usher in more
By Sylvia Pagan Westphal, Boston Globe, December 23, 2010
12-16-10 Drug-Resistant Genes Spread among Bacteria
Unlike other superbugs, a new class of antibiotic-resistant bacteria are gaining their power from easily transferable genes such as NDM-1
By Katherine Harmon, Scientific America, December 16, 2010
12-07-10 Are We Running Out of Antibiotics?
As more bacteria become resistant to the most powerful drugs in our arsenal, new weapons are getting harder and harder to find. Why we need to change the way we think about treating infection.
By Jeneen Interlandi, Newsweek, December 7, 2010
11-5-10 Antibiotics Research Subsidies Weighed by U.S.
Worried about an impending public health crisis, government officials are considering offering financial incentives to spur the development of vitally needed antibiotics.
By Andrew Pollack, New York Times, November 5, 2010
9-29-10 Potentially lethal infections imperil already injured troops
Wounded American military personnel may survive a roadside bomb attack in Iraq only to face possible death later in a U.S. hospital from drug-resistant infection.
By Charley Keyes, CNN, September 29, 2010
8-6-10 Arsenal of antibiotics not being restocked
Dispute over rules for approving new drugs stalls production even as concern rises over deadly resistant bacteria
By Trine Tsouderos, Chicago Tribune, August 6, 2010
7-7-10 ESBL: A greater danger than MRSA?
MRSA is not alone - other pathogens are proving their resistance to antibiotics including gram-negative enterobacteria, which has joined the list of nasty ‘superbugs’.
By Karoline Laarmann, European Hospital, July 7, 2010
3-6-10 The Spread of Superbugs
Agricultural use of antibiotics produces cheaper meat but the price may be an enormous toll in human health.
By Nicholas D. Kristof, New York Times, March 6, 2010
2-26-10 Rising Threat of Infections Unfazed by Antibiotics
By Andrew Pollack, New York Times, February 26, 2010
2-26-10 Deadly Germs Largely Ignored By Drug Firms
Gram-negative bacteria are practically built to withstand drugs, which is one reason few drug makers have rushed to pursue treatments.
By Andrew Pollack, New York Times, February 26, 2010
|
